These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4382337)

  • 1. The mechanism of the tranquillizing action of asarone from Acorus calamus Linn.
    Menon MK; Dandiya PC
    J Pharm Pharmacol; 1967 Mar; 19(3):170-5. PubMed ID: 4382337
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioural action and tranquillizing effect of reserpine, diazepam and hydroxyzine.
    Molinengo L; Gamalero SR
    Arch Int Pharmacodyn Ther; 1969 Jul; 180(1):217-31. PubMed ID: 5357007
    [No Abstract]   [Full Text] [Related]  

  • 3. Similarities between delta9-tetrahydrocannabinol (delta9-THC) and reserpine-like drugs.
    Carder B; Deikel SM
    Behav Biol; 1976 Jul; 17(3):313-32. PubMed ID: 971187
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of action of anticonvulsants. I. Diphenylhydantoin.
    Rudzik AD; Mennear JH
    Life Sci; 1965 Dec; 4(24):2373-82. PubMed ID: 5879554
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

  • 7. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
    McKearney JW
    J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of tricyclic antidepressants and neuroleptics on the peripheral and central action of norepinephrine in reserpine-treated mice.
    Nakamura M; Fukushima H
    Eur J Pharmacol; 1976 Aug; 38(2):343-8. PubMed ID: 954847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological study of 1-(beta-phenylethyl) triazolo (4,5-c) pyridine hydrochloride, a tranquillizing agent.
    Ahmad A; Vohra MM; Achari G
    Jpn J Pharmacol; 1967 Dec; 17(4):622-30. PubMed ID: 5301352
    [No Abstract]   [Full Text] [Related]  

  • 11. Affective disorders and norepinephrine pharmacology.
    Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
    Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
    [No Abstract]   [Full Text] [Related]  

  • 12. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 13. Difference in oral effectiveness of two tyrosine hydroxylase inhibitors.
    Johnson GA; Kim EG; Veldkamp W; Russell R
    Biochem Pharmacol; 1967 Feb; 16(2):401-3. PubMed ID: 6029921
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological studies on tetrabenazine-induced excited behaviour of rats pretreated with amphetamine or nialamide.
    Scheel-Krüger J; Jonas W
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):47-65. PubMed ID: 4798103
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological modifications on the amphetamine-induced hyperthermia in rats.
    Morpurgo C; Theobald W
    Eur J Pharmacol; 1968 Feb; 2(4):287-94. PubMed ID: 5642032
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of the effects of tranquilizers in animals treated with alpha-methyl-l-tryrosine.
    Menon MK; Dandiya PC; Bapna JS
    J Pharmacol Exp Ther; 1967 Apr; 156(1):63-9. PubMed ID: 6023601
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitation of drug effects upon conditioned avoidance behavior in the rat.
    ASTON R; SEKINO E; GREIFENSTEIN E
    Toxicol Appl Pharmacol; 1962 May; 4():393-401. PubMed ID: 13863003
    [No Abstract]   [Full Text] [Related]  

  • 19. Central nervous system studies on an ethanol extract of Acorus calamus rhizomes.
    Vohora SB; Shah SA; Dandiya PC
    J Ethnopharmacol; 1990 Feb; 28(1):53-62. PubMed ID: 2314110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of neuroleptic drugs on the conditioned behavior after pretreatment with alpha-methyltyrosine or p-chlorophenylalanine.
    Oka M; Kamei C; Shimizu M
    Jpn J Pharmacol; 1977 Dec; 27(6):807-15. PubMed ID: 147354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.